Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Celecoxib examined for effects on progression of AD in elderly in a 52-week study

May 5, 2000

Tau protein kinase 1 inhibitors in development at Mitsubishi-Tokyo Pharmaceuticals

May 5, 2000

Widely used anesthetic greatly reduces pain during rectal prostate biopsy

May 4, 2000

SmithKline Beecham seeks marketing clearance for Paxil in GAD

May 4, 2000

Sertraline efficacious in treating posttraumatic stress disorder

May 4, 2000

Development of glycine antagonist for stroke discontinued by Glaxo Wellcome

May 3, 2000

Adverse effects reported for ziconotide, a treatment for pain and for spasticity

May 3, 2000

Caspase inhibition slows ALS onset and improves survival in mice

May 3, 2000

Frovatriptan is approvable, FDA says; first European approval also in sight

May 2, 2000

Schering presents recent research in the area of NOS inhibitors

May 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...